When federal regulators last week approved Digene Corp.'s cervical cancer test as a primary screening tool for women over 30, they catapulted what had been a follow-up test into direct competition ...
I have a condition called vaginismus that makes traditional cervical cancer screening nearly impossible.
NEW YORK, Jan 12 (Reuters) - Digene Corp's new chief executive officer said on Friday the company could not afford to remain "a one-product company" and would aim to disclose a strategy of moving ...
“Finding a cure for cancer” is synonymous in our society with the ultimate in success. And yet Digene (DIGE $37), which sells a test that could eradicate cervical cancer, meets with tepid enthusiasm ...
Regular cervical cancer screening using HPV testing and/or Pap tests can prevent up to 90% or more of cervical cancers by detecting and treating precancerous lesions early, making it one of the most ...
Digene Corp., a Gaithersburg company that sells DNA-based tests to detect diseases, is jumping into the growing market for drug-research tools that analyze genetic activity. Digene announced yesterday ...
Self-swab HPV tests provide a simple way to catch early warning signs of cervical cancer in or away from a doctor's office.